Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Ранг среди акций #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Цена акции
$9.60
Последняя синхронизация: 2025-05-21
Рыночная капитализация
$1.08B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля OptiNose, Inc. (OPTN)

Категория

Прибыль OptiNose, Inc. (OPTN)
Прибыль на Mar 2025 TTM: $-29.89M
Согласно последним финансовым отчетам OptiNose, Inc., текущая прибыль компании составляет $-29.89M. В 2023 году компания получила прибыль $-35.48M, больше, чем прибыли за 2022, которая составила $-74.83M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании OptiNose, Inc. с 2015 по 2026
Прибыль в конце каждого года
Год Прибыль Изменить
2026 (TTM) $-29.89M 38.76%
2024 $-21.54M -39.29%
2023 $-35.48M -52.58%
2022 $-74.83M -9.07%
2021 $-82.30M -17.53%
2020 $-99.79M -9.33%
2019 $-110.05M 3.18%
2018 $-106.66M 118.11%
2017 $-48.90M -316.26%
2016 $22.61M -179.87%
2015 $-28.31M 0.00%
Прибыль схожих компаний или конкурентов
Компания Прибыль Разница в прибыли Страна
- -
DE
- -
DE
- -
JP
- -
CH
$1.76B -6,003.49%
IN